• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TXMD

TXMD

TherapeuticsMD, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD1.97

-0.07 (-3.43%)

Rating:B

Company Profile

CEO

Marlan D. Walker

IPO Date

2007-05-09

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.03

Prev. Close

$2.04

Day Low

$1.94

Day High

$2.04

52W Low

$0.98

52W High

$2.95

Market Cap

$0.02B

Volume

0.04M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

51.6%

Avg Negative

10.7%

Avg Neutral

38.0%

News Feed

TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021

Business Wire·7/26/2021·↑ positive

TherapeuticsMD: The Long Road To Profitability

Seeking Alpha·7/8/2021·↑ positive

TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA

Business Wire·5/25/2021·↑ positive

The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award

Business Wire·5/24/2021·↑ positive

TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/6/2021·↓ negative

TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume

Benzinga·5/6/2021·↑ positive

TherapeuticsMD: Fighting To Regain Support Above $1.20

Seeking Alpha·4/21/2021·↑ positive

TherapeuticsMD: Great Product, But We Are Underwhelmed By Execution

Seeking Alpha·4/21/2021·↓ negative

TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday

InvestorPlace·4/9/2021·↑ positive

TherapeuticsMD Stock Price Increased Over 10% Pre-Market: Why It Happened

Pulse2·4/9/2021·↑ positive